To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
Clinical trial NCT07280494 · RECRUITING
Trial details
- NCT number
- NCT07280494
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2026-08-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.